HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Details

Daily high

$1.62

Daily low

$1.46

Price at open

$1.48

52 Week High

$3.93

52 Week Low

$1.04

Market cap

240.3M

Dividend yield

0.00%

Volume

2.6M

Avg. volume

6.4M

P/E ratio

-8.56

Heron Therapeutics News